{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:24:42Z","timestamp":1760502282132,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Boehringer Ingelheim Animal Health, Inc.","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Porcine parvovirus 1 (PPV1) is widespread in commercial pig farms worldwide and has a significant impact to the swine industry. Long-lasting immunity achieved by means of vaccination is the main tool to prevent PPV1 infection and its associated clinical signs. Here we evaluated the duration of immunity (DOI) conferred by a novel subunit vaccine based on the viral protein (VP) 2 of PPV1, named ReproCyc\u00ae ParvoFLEX. The DOI was assessed at 6 months post-vaccination following the standard vaccination scheme (phase I) or after re-vaccination (phase II) with a single injection administered 24\u2009weeks after the basic vaccination scheme. A total of 46, five to six-month-old gilts, free of PPV1 and porcine reproductive and respiratory syndrome virus (PRRSV), were randomly assigned to 6 groups (three in each phase): the negative control groups were inoculated with sodium chloride (NaCl), the vaccinated groups were immunized with the PPV1 subunit vaccine and the strict controls were neither treated nor challenged. Subsequently, the negative control and vaccinated groups from each phase were challenged with a heterologous PPV1 strain. Infection of fetuses was the primary outcome parameter for efficacy, though other supportive parameters were PPV1 viremia and serological status of the gilts and the condition of their fetuses (i.e. normal, autolytic, or mummified).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>All gilts vaccinated against PPV1 tested seropositive at challenge and viremia after challenge was detectable only in the non-vaccinated animals. In this regard, fetuses positive to PPV1 by PCR were only found in litters from non-vaccinated sows.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>These results point out that the immunity developed by the PPV1 subunit vaccine is effective in terms of preventing viremia, transplacental infection of fetuses and fetal death caused by PPV1 infection. ReproCyc\u00ae ParvoFLEX was demonstrated to protect fetuses against heterologous PPV1 challenge with a DOI of 6\u2009months after vaccination.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12917-020-02394-4","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T13:20:04Z","timestamp":1591708804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Duration of immunity against heterologous porcine parvovirus 1 challenge in gilts immunized with a novel subunit vaccine based on the viral protein 2"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-9932","authenticated-orcid":false,"given":"Beatriz","family":"Garcia-Morante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Noguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Klocke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Bridger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"2394_CR1","unstructured":"Truyen U, Streck AF. Porcine parvovirus. In: Zimmerman JK, Karriker L, Ramirez A, Schwartz KJ, Stevenson GW, editors. Diseases of Swine. 10th ed: Wiley-Blackwell; 2012. p. 447\u201355."},{"key":"2394_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/v9120393","volume":"9","author":"I M\u00e9sz\u00e1ros","year":"2017","unstructured":"M\u00e9sz\u00e1ros I, Olasz F, Cs\u00e1gola A, Tijssen P, Z\u00e1dori Z. Biology of porcine parvovirus (Ungulate parvovirus 1). Viruses. 2017;9:12.","journal-title":"Viruses."},{"key":"2394_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1751-0813.1993.tb06124.x","volume":"70","author":"CR Parke","year":"1993","unstructured":"Parke CR, Burgess GW. An economic assessment of porcine parvovirus vaccination. Aust Vet J. 1993;70:5.","journal-title":"Aust Vet J"},{"key":"2394_CR4","doi-asserted-by":"crossref","unstructured":"Streck AF, Canal CW, Truyen U. Molecular epidemiology evolution of porcine parvoviruses. Infect Genet Evol. 2015;36.","DOI":"10.1016\/j.meegid.2015.10.007"},{"key":"2394_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1006\/viro.1993.1288","volume":"194","author":"MS Chapman","year":"1993","unstructured":"Chapman MS, Rossmann MG. Structure, sequence, and function correlations among parvoviruses. Virology. 1993;194:2.","journal-title":"Virology."},{"key":"2394_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1006\/jmbi.2001.5319","volume":"315","author":"AA Simpson","year":"2002","unstructured":"Simpson AA, H\u00e9bert B, Sullivan GM, Parrish CR, Z\u00e1dori Z, Tijssen P, et al. The structure of porcine parvovirus: comparison with related viruses. J Mol Biol. 2002;315:5.","journal-title":"J Mol Biol"},{"key":"2394_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/vir.0.012054-0","volume":"90","author":"A J\u00f3\u017awik","year":"2009","unstructured":"J\u00f3\u017awik A, Manteutel J, Selbitz HJ, Truyen U. Vaccination against porcine parvovirus protects against disease, but does not prevent infection and virus shedding after challenge infection with a heterologous virus strain. J Gen Virol. 2009;90:10.","journal-title":"J Gen Virol"},{"key":"2394_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1089\/08828240260066297","volume":"15","author":"AS Ladekj\u00e6r-Mikkelsen","year":"2002","unstructured":"Ladekj\u00e6r-Mikkelsen AS, Nielsen J. A longitudinal study of cell-mediated immunity in pigs infected with porcine parvovirus. Viral Immunol. 2002;15:2.","journal-title":"Viral Immunol"},{"key":"2394_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1099\/vir.0.82302-0","volume":"88","author":"EJ Zeeuw","year":"2007","unstructured":"Zeeuw EJ, Leinecker N, Herwig V, Selbitz HJ, Truyen U. Study of the virulence and cross-neutralization capability of recent porcine parvovirus field isolates and vaccine viruses in experimentally infected pregnant gilts. J Gen Virol. 2007;88:2.","journal-title":"J Gen Virol."},{"key":"2394_CR10","first-page":"11","volume":"29","author":"Q Hong","year":"2007","unstructured":"Hong Q, Qian P, Li XM, Yu XL, Chen HC. A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate. Biotechnol Lett. 2007;29:11.","journal-title":"Biotechnol Lett"},{"key":"2394_CR11","first-page":"11","volume":"18","author":"Y Xu","year":"2011","unstructured":"Xu Y, Cui L, Tian C, Zhang G, Huo G, Tang L, et al. Immunogenicity of recombinant classic swine fever virus CD8+T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination. Clin Vaccine Immunol. 2011;18:11.","journal-title":"Clin Vaccine Immunol"},{"key":"2394_CR12","doi-asserted-by":"crossref","unstructured":"Zimmermann P, Ritzmann M, Selbitz HJ, Heinritzi K, Truyen U. VP1 sequences of German porcine parvovirus isolates define two genetic lineages. J Gen Virol. 2006;87.","DOI":"10.1099\/vir.0.81086-0"},{"key":"2394_CR13","doi-asserted-by":"crossref","unstructured":"Streck AF, Homeier T, Foerster T, Truyen U. Population dynamics and in vitro antibody pressure of porcine parvovirus indicate a decrease in variability. J Gen Virol. 2013;94.","DOI":"10.1099\/vir.0.052555-0"},{"key":"2394_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-019-2207-z","volume":"16","author":"E Van Den Born","year":"2020","unstructured":"Van Den Born E, Van Den Elzen PPM, Van Kilsdonk E, Hoeijmakers MJH, Segers RPAM. An octavalent vaccine provides pregnant gilts protection against a highly virulent porcine parvovirus strain. BMC Vet Res. 2020;16:1.","journal-title":"BMC Vet Res"},{"key":"2394_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.heliyon.2019.e02593","volume":"5","author":"B Garcia-Morante","year":"2019","unstructured":"Garcia-Morante B, Noguera M, Klocke S, Sommer K, Kaiser T, Haist V, et al. A novel subunit vaccine based on the viral protein 2 of porcine parvovirus: safety profile in bred pigs at different stages of the reproduction cycle and in offspring. Heliyon. 2019;5:11.","journal-title":"Heliyon."},{"key":"2394_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1099\/jgv.0.000446","volume":"97","author":"T Foerster","year":"2016","unstructured":"Foerster T, Streck AF, Speck S, Selbitz HJ, Lindner T, Truyen U. An inactivated whole-virus porcine parvovirus vaccine protects pigs against disease but does not prevent virus shedding even after homologous virus challenge. J Gen Virol. 2016;97:6.","journal-title":"J Gen Virol."},{"key":"2394_CR17","first-page":"6","volume":"60","author":"PG Lawlor","year":"2011","unstructured":"Lawlor PG, Lynch PB. A review of factors influencing litter size in Irish sows. Ir Vet J. 2011;60:6.","journal-title":"Ir Vet J"},{"key":"2394_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-4320(02)00225-7","volume":"75","author":"T Van Der Lende","year":"2003","unstructured":"Van Der Lende T, Van Rens BT. Critical periods for foetal mortality in gilts identified by analysing the length distribution of mummified foetuses and frequency of non-fresh stillborn piglets. Anim Reprod Sci. 2003;75:1\u20132.","journal-title":"Anim Reprod Sci"},{"key":"2394_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ani9110885","volume":"9","author":"P Langendijk","year":"2019","unstructured":"Langendijk P, Plush K. Parturition and its relationship with stillbirths and asphyxiated piglets. Animals. 2019;9:11.","journal-title":"Animals."},{"key":"2394_CR20","first-page":"6","volume":"8","author":"C Kilkenny","year":"2013","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2013;8:6.","journal-title":"PLoS Biol"},{"key":"2394_CR21","unstructured":"Brussow KP, Schneider F, Kanitz W, Ratky J, Kauffold J, Wahner M. Studies on fixed-time ovulation induction in the pig. Soc Reprod Fertil Suppl. 2009;66."},{"key":"2394_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0166-0934(91)90051-Z","volume":"32","author":"TW Molitor","year":"1991","unstructured":"Molitor TW, Oraveerakul K, Zhang QQ, Choi CS, Ludemann LR. Polymerase chain reaction (PCR) amplification for the detection of porcine parvovirus. J Virol Methods. 1991;32:2\u20133.","journal-title":"J Virol Methods"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02394-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02394-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02394-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T23:27:27Z","timestamp":1623194847000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02394-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2394"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02394-4","relation":{},"ISSN":["1746-6148"],"issn-type":[{"type":"electronic","value":"1746-6148"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Ethical Committee of the LAVES organization (Lower Saxony State Office for Consumer Protection and Food Safety). In addition, this study was conducted in accordance with Good Clinical Practices, VICH Guideline GL9, CVMP\/VICH\/595\/98-Final; Directive 2001\/82\/EC of the European Parliament and of the Council of the Community Code to Veterinary Medicinal Products (as amended in 2009), EMA\/CVMP\/IWP\/594618\/2010 and Ph. Eur. Monograph\u00a00965.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Boehringer Ingelheim Animal Health, Inc. sponsored the clinical trials reported in this publication through professional veterinary and research support. Dr. Beatriz Garcia Morante is an external researcher consultant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}